Moreover, SLFN11 has been recently studied in relation with the immune system (6, 12), especially in breast cancer (13), and for its potential role as an endogenous inhibitor of viral replication (14) and translation of DNA damage response proteins (15). Here, SLFN11 is linked to breast cancer.